MedTrace Logo

Human Optokinetic Contrast Device (HOCD) to Measure Visual Function and Identify Patients With and Without Glaucoma

NCT02014597 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2023-05-11

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if an optokinetic contrast detection device is sufficient to measure contrast sensitivity and to distinguish between patients with and without glaucoma.

Conditions

Interventions

DEVICE

HOCD

feasibility of HOCD and comparison of HOCD results between subjects with and without glaucoma

Sponsors & Collaborators

  • Benjamin Frankfort, MD, PhD

    lead OTHER

Principal Investigators

  • Benjamin J. Frankfort, M.D. PhD. · Baylor College of Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2017-08-22
Completion
2017-08-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02014597 on ClinicalTrials.gov